Paul Tudor Jones's RXST Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 150,960 shares of RxSight, Inc. (RXST) worth $929,914, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in RXST, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 131,655 shares. Largest reduction occurred in Q3 2023, reducing 57,011 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's RxSight (RXST) Holding Value Over Time
Track share changes against reported price movement
Quarterly RxSight (RXST) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +131,655 | Add 681.97% | 150,960 | $6.16 |
| Q4 2025 | +19,305 | New Buy | 19,305 | $10.42 |
| Q3 2025 | -51,262 | Sold Out | 0 | $0.00 |
| Q2 2025 | -36,042 | Reduce 41.28% | 51,262 | $13.00 |
| Q1 2025 | +19,166 | Add 28.13% | 87,304 | $25.25 |
| Q4 2024 | +36,669 | Add 116.52% | 68,138 | $34.38 |
| Q3 2024 | -51,647 | Reduce 62.14% | 31,469 | $49.43 |
| Q2 2024 | -3,886 | Reduce 4.47% | 83,116 | $60.17 |
| Q1 2024 | +87,002 | New Buy | 87,002 | $51.58 |
| Q4 2023 | -27,908 | Sold Out | 0 | $0.00 |
| Q3 2023 | -57,011 | Reduce 67.14% | 27,908 | $27.89 |
| Q2 2023 | +84,919 | New Buy | 84,919 | $28.80 |
Paul Tudor Jones's RxSight Investment FAQs
Paul Tudor Jones first purchased RxSight, Inc. (RXST) in Q2 2023, acquiring 84,919 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held RxSight, Inc. (RXST) for 12 quarters since Q2 2023.
Paul Tudor Jones's largest addition to RxSight, Inc. (RXST) was in Q1 2026, adding 150,960 shares worth $929,914.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 150,960 shares of RxSight, Inc. (RXST), valued at approximately $929,914.
As of the Q1 2026 filing, RxSight, Inc. (RXST) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in RxSight, Inc. (RXST) was 150,960 shares, as reported at the end of Q1 2026.